Article
The use of cytogenetic microarrays in myelodysplastic syndrome characterization.
Methods in molecular biology (Clifton, N.J.) - 1 Jan 2013
Shaffer Lisa G, Ballif Blake C, Schultz Roger A
Abstract excerpt
Various microarray platforms, including BAC, oligonucleotide, and SNP arrays, have been shown to -provide clinically useful diagnostic and prognostic information for patients with myelodysplastic syndromes (MDS). Clinically useful arrays are designed with specific purposes in mind and with attention to genomic content and probe density. All array types have been shown to detect genomic copy gains and losses, with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.